Zomedica Corp.

ZOMDF Healthcare Medical Devices

Zomedica Corp.’s revenue for fiscal 2025 (year ended December 2025) was $32.0 million, up 17.4% from fiscal 2024. In the quarter to June 2026, revenue grew 36.6%, EPS grew 49.3% and free cash flow grew 40.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

0.08 0.00 0.00%
Market cap
$95.4M
P/E
0.0×
Fwd P/E
−1.9×
Dividend yield
—
F-score
4/9
Altman Z
0.42
Beneish M
−5.04
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

4 4 5 5
ROE
(52.41%) (52.63%) (18.56%) (16.29%)
ROA
(49.00%) (48.96%) (17.07%) (14.88%)
ROIC
(82.02%) (84.84%) (24.34%) (20.54%)
Return on Tangible Assets
(108.86%) (108.41%) (31.40%) (27.49%)
Average Days of Receivables
44.98 39.37 51.05 59.63
Free Cash Flow per Share
(0.02) (0.02) (0.02) (0.02)
Free Cash Flow
(24.11) (18.59) (17.32) (15.03)
Other line items

Show all line items

Columns are period end dates